Drug repositioning

Outbreak

Pathology

Virology

Intensive care medicine

Ecology

Coronavirus

Betacoronavirus

Hydroxychloroquine

Disease

Drug

Coronavirus Infections

2019-20 coronavirus outbreak

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Coronavirus disease 2019 (COVID-19)

Repurposing

Infectious disease (medical specialty)

Clinical trial

Medicine

Biology

Pandemic

Pharmacology

Nature Reviews Drug Discovery

Therapeutic options in response to the 2019-nCoV outbreak are urgently needed. Here, we discuss the potential for repurposing existing antiviral agents to treat 2019-nCoV infection (now known as COVID-19), some of which are already moving into clinical trials. Therapeutic options in response to the 2019-nCoV outbreak are urgently needed. Here, we discuss the potential for repurposing existing antiviral agents to treat 2019-nCoV infection (now known as COVID-19), some of which are already moving into clinical trials.

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)